Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 811
Gene Symbol: CALR
CALR
CUI: C0025167
Disease: Megakaryocytic hyperplasia
Megakaryocytic hyperplasia
0.010 Biomarker BEFREE JAK2-mutated MPN showed erythroid, granulocytic and/or megakaryocytic hyperplasia whereas CALR- and MPL-mutated MPNs displayed granulocytic and/or megakaryocytic hyperplasia. 27444979

2016

Entrez Id: 4352
Gene Symbol: MPL
MPL
CUI: C0025167
Disease: Megakaryocytic hyperplasia
Megakaryocytic hyperplasia
0.010 GeneticVariation BEFREE JAK2-mutated MPN showed erythroid, granulocytic and/or megakaryocytic hyperplasia whereas CALR- and MPL-mutated MPNs displayed granulocytic and/or megakaryocytic hyperplasia. 27444979

2016

Entrez Id: 3717
Gene Symbol: JAK2
JAK2
CUI: C0025167
Disease: Megakaryocytic hyperplasia
Megakaryocytic hyperplasia
0.010 GeneticVariation BEFREE All bone marrow biopsies of JAK2(V617F)-mutated CMML showed increased erythropoiesis, a marked myeloid and megakaryocytic hyperplasia with occasionally clustered megakaryocytes, and a mild or moderate (grade 1 or 2) fibrosis; six cases showed an increased number of dilated sinusoids and reactive lymphoid nodules. 19734476

2009

Entrez Id: 7852
Gene Symbol: CXCR4
CXCR4
CUI: C0025167
Disease: Megakaryocytic hyperplasia
Megakaryocytic hyperplasia
0.010 Biomarker BEFREE This study investigated the involvement of chemokines including stromal derived factor 1 (SDF-1), interleukin 8 (IL-8), growth-related oncogene alpha (GRO-alpha) and their receptors, CXCR4, CXCR2 and CXCR1 in essential thrombocythemia (ET), a chronic myeloproliferative disease characterized by megakaryocytic hyperplasia and high platelet count.Fifty-three ET patients were studied. 19006565

2009

Entrez Id: 6387
Gene Symbol: CXCL12
CXCL12
CUI: C0025167
Disease: Megakaryocytic hyperplasia
Megakaryocytic hyperplasia
0.010 Biomarker BEFREE This study investigated the involvement of chemokines including stromal derived factor 1 (SDF-1), interleukin 8 (IL-8), growth-related oncogene alpha (GRO-alpha) and their receptors, CXCR4, CXCR2 and CXCR1 in essential thrombocythemia (ET), a chronic myeloproliferative disease characterized by megakaryocytic hyperplasia and high platelet count.Fifty-three ET patients were studied. 19006565

2009

Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
CUI: C0025167
Disease: Megakaryocytic hyperplasia
Megakaryocytic hyperplasia
0.010 Biomarker BEFREE This study investigated the involvement of chemokines including stromal derived factor 1 (SDF-1), interleukin 8 (IL-8), growth-related oncogene alpha (GRO-alpha) and their receptors, CXCR4, CXCR2 and CXCR1 in essential thrombocythemia (ET), a chronic myeloproliferative disease characterized by megakaryocytic hyperplasia and high platelet count.Fifty-three ET patients were studied. 19006565

2009

Entrez Id: 5047
Gene Symbol: PAEP
PAEP
CUI: C0025167
Disease: Megakaryocytic hyperplasia
Megakaryocytic hyperplasia
0.010 Biomarker BEFREE In addition to the expected thrombocytosis after 7 to 10 days of daily injection of high doses of PEG-rHuMGDF, a transient decrease in peripheral red blood cell numbers and hemoglobin is noted accompanied in the bone marrow by megakaryocytic hyperplasia, myeloid hyperplasia, erythroid and lymphoid hypoplasia, and deposition of a fine network of reticulin fibers. 8652813

1996

Entrez Id: 7939
Gene Symbol: LAP
LAP
CUI: C0025167
Disease: Megakaryocytic hyperplasia
Megakaryocytic hyperplasia
0.010 Biomarker BEFREE Typical features of AMM include leukoerythroblastosis, teardrop poikilocytosis, anemia, increased or normal LAP, prominent megakaryocytic hyperplasia in the marrow, dyshematopoiesis, and hyperplastic or fibrotic/sclerotic marrow. 2272176

1990